Allakos Inc. (ALLK)
NASDAQ: ALLK · Real-Time Price · USD
0.939
-0.071 (-7.01%)
At close: Nov 20, 2024, 4:00 PM
1.010
+0.071 (7.54%)
After-hours: Nov 20, 2024, 6:07 PM EST
Allakos Employees
Allakos had 131 employees as of December 31, 2023. The number of employees increased by 8 or 6.50% compared to the previous year.
Employees
131
Change (1Y)
8
Growth (1Y)
6.50%
Revenue / Employee
n/a
Profits / Employee
-$1,364,466
Market Cap
83.91M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Inotiv | 2,055 |
So-Young International | 1,357 |
WORK Medical Technology Group LTD | 216 |
OptimizeRx | 136 |
LENSAR | 130 |
PMV Pharmaceuticals | 63 |
Ikena Oncology | 43 |
Oncolytics Biotech | 29 |
ALLK News
- 14 days ago - Allakos Runs Up Into A Near-Term Catalyst - Seeking Alpha
- 14 days ago - Allakos Provides Business Update and Reports Third Quarter 2024 Financial Results - GlobeNewsWire
- 5 weeks ago - Allakos Announces Phase 1 Trial Results of Subcutaneous AK006 in Healthy Volunteers - GlobeNewsWire
- 3 months ago - Allakos Provides Business Update and Reports Second Quarter 2024 Financial Results - GlobeNewsWire
- 5 months ago - The Schall Law Firm Begins Probe Into Claims Against Allakos Inc And Urges Affected Investors To Participate - Accesswire
- 5 months ago - The Schall Law Firm Initiates Investigation Into Allegations Against Allakos Inc And Encourages Impacted Investors To Engage - Accesswire
- 5 months ago - Allakos Announces Positive Results from its Ongoing Phase 1 Trial of AK006 in Healthy Volunteers, with AK006 Demonstrating High Receptor Occupancy on Mast Cells and a Favorable Safety Profile - GlobeNewsWire
- 5 months ago - The Schall Law Firm Initiates Investigation Into Allegations Against Allakos Inc And Encourages Impacted Investors To Join - Accesswire